24 May 2017:
Prof Mark Hutchinson has hosted a visit to the University of Adelaide and CNBP Headquarters of His Excellency Mr Pedro Zwahlen, Ambassador of Switzerland to Australia.
The visit from the Ambassador was a part of a four day trip to Adelaide which included visits to the Tonsley Innovation Precinct, the South Australian Health and Medical Research Institute, various South Australian Government Departments, as well as meetings with the Honourable Jack Snelling MP and the Honourable Zoe Bettison MP.
As a part of the Ambassador’s visit to the University of Adelaide, Prof Hutchinson discussed CNBP science activity, the power of light to measure in the body, and provided a walk-through tour of the Centre’s laboratories.
Below – Prof Mark Hutchinson left, with His Excellency Mr Pedro Zwahlen.
23 November 2016:
Centre personnel, laboratories and microscopes were on display at Macquarie University, Wednesday November 23rd, as guests from industry partner Olympus Australia took time out of their busy schedules to visit and to explore the latest in imaging developments taking place at the CNBP.
Hosted by CNBP node leader Prof Jim Piper and CNBP Associate Investigator Dr Yiqing Lu, Olympus Australia’s Kim Everuss (Sales Manager, MIS), Jian Shen (Marketing Manager, MIS), Chunsong Yan (Customer Experience Service Manager) and Clare Kelly (Product Manager specialising in confocal microscopy) were shown the latest in CNBP research, spoke with CNBP researchers and actively inspected tools and techniques related to the Centre’s luminescence related microscopy activity. Of particular focus was Centre work on a ‘plug and play’ time-gated imaging module that could be easily linked to current Olympus microscope setups.
Presentations from CNBP researchers also took place during the visit, outlining biological applications including biomedical diagnostics and drug delivery and leading edge research in the biology of pain.
Prof Jim Piper noted that the visit further cemented the fantastic relationship between the two organisations and that he looked forward to working closely with Olympus Australia with a view to facilitating industry-research benefits for both parties.
Below – CNBP Associate Investigator Dr Yiqing Lu explains the technology involved in the innovative time-gated imaging module.
16 November 2016:
Professor Mark Hutchinson (Director, CNBP) has attended the Society for Neuroscience (SfN) Conference held in San Diego, 12-16th November 2016 and presented a poster with the abstract ‘Does the allodynic spinal cord have a specific colour?’
While in San Diego, Prof Hutchinson also attended the Frontiers in Addiction Research Mini-Convention – ‘Relapse and Recovery: from Mechanistic Understanding to Translational Research.’
Following the conference, the Director (and several members of his team) travelled to Colorado where they visited partner investigators at the University of Colorado Boulder (17th and 18th November 2016) where the latest in CNBP research findings were presented and discussed.
14 November 2016:
Dr Sanam Mustafa has organised the visit to CNBP of a key player in the field of G protein-coupled receptors research, Professor Graeme Milligan.
The visit will take place in Adelaide, Friday 25th November 2016 – If you would like to chat with Professor Milligan please contact Dr Sanam Mustafa via email (firstname.lastname@example.org).
Professor Milligan’s main research group centres on the function, structure and regulation of G protein-coupled receptors (GPCRs) and their interacting proteins. He has published some 500 peer-reviewed articles on these topics. His research has been cited more than 24,000 times. Professor Graeme Milligan graduated with a Bachelor of Science in Biochemistry from the University of Birmingham. He went on to do his PhD at the University of Nottingham. Graeme was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and, amongst various honours, was the recipient of the Ariens Award for pharmacology from the Dutch Pharmacological Society in 2006 and the JR Vane Medal for Pharmacology from the British Pharmacological Society in 2016. Professor Milligan is currently a Professor of Molecular Pharmacology, Dean of Research, College of Medical, Veterinary and Life Sciences and a Gardiner Professor of Biochemistry at the University of Glasgow. Professor Milligan is also a non-executive director and co-founder of the company Caldan Therapeutics which is searching for novel treatments for type II diabetes.
Professor Milligan will first present a keynote address at the Adelaide Pharmacology Group Meeting at the National Wine Centre on Friday 25th, followed by an afternoon tour of CNBP and one-to-one meetings.
15 August 2016:
Dr Christopher Paige, from CNBP research partner organisation University Health Network (UHN/University of Toronto) visited the Centre for Nanoscale BioPhotonics (CNBP) on 15 August 2016 to discuss how the Canadian funding system is working, MRFF/NHMRC Reviews and broader collaboration in general.
Whilst at CNBP he attended a lunch hosted by the DVCR (Mike Brooks) and was given a tour of both CNBP and SAHMRI facilities.
The visit follows on from a successful partnership launch between the two organisations in May 2016.
22 July 2016:
Dr Michael Baratta from The University of Colorado Boulder recently visited both the Macquarie and Adelaide nodes of the CNBP during July 2016.
Whilst at both nodes he presented a seminar titled, “Targeting and readout strategies for studying the neural basis of stress resilience,” and spoke with staff and students. This resulted in several potential collaboration projects being discussed in greater detail.
Michael was the successful recipient of the CNBP-American Australian Association (AAA) Fellowship for 2016 and will also be returning to Australia in the next 12 months to continue his CNBP interactions.
17 June 2016:
A CNBP workshop tailored for early career researchers (ECRs) was held at Macquarie University, June 17th, 2016.
A full-house saw a number of topics discussed, including:
-how to write a successful grant and how to respond to grant feedback (from CNBP ECRs with current successful ARC Fellowships).
-an update of key points discussed at the CNBP Executive Management Committee meeting
-and a Q&A session discussing differences in industry versus an academic research focus.
During this event, attendees were also honored to welcome Mal Eutick, CEO of Phebra Australia. Mal was generous enough to share his experiences/advice on biomedical commercialization and industry. He had several insightful interactions with CNBP ECRs about topics ranging from procuring investor funding to product development and distribution in Australia and worldwide.
Feedback from all participants was positive with Mal and his observations on industry focused opportunities prompting a high level of engagement and interest.
In addition, approximately 40 of the attending CNBP ECRs undertook a social networking event, held on a Sydney harbor-boat cruise on the evening of June 16th. This too receiving extremely positive feedback.
26 May 2016:
Representatives from US Defense Force science and research offices were today hosted by CNBP researchers at Macquarie University.
The visit, organised by the Australian National Fabrication Facility (ANFF), included informal talks as well as visits to CNBP’s biology, biophotonics, optics and materials laboratories.
The laboratory visits gave CNBP researchers the opportunity to showcase their work with an overview of CNBP activity and research direction also provided. Discussed were potential synergies and areas of collaboration.
Below, CNBP Associate Investigator Dr Alf Garcia-Bennett discusses his work on protein corona formation on nanoparticles.
14 March 2016:
Prof Leonard Harrison from the Walter and Eliza Hall Institute of Medical Research (Melbourne) has given an invited talk to researchers at Macquarie University.
Invited by CNBP PhD student Abdulrahman (Shaz) Mansour M Shathili and CNBP Chief Investigator Prof Nicki Packer, Prof Harrison spoke about his work on a novel immunoregulatory mechanism whereby soluble CD52, released from activated T cells, suppresses other T cells and innate immune cells via Siglec receptor pathways.
Also discussed was the therapeutic potential resulting from this investigation.
11 March 2016:
John Gardner MP (Liberal Shadow Minister for Education; Multicultural Affairs; The Arts and Higher Education, Science and the Information Economy) and SA State Member for Morialta, took time out to visit CNBP and the University of Adelaide on Friday March 11th, 2016.
Meeting with CNBP Director Mark Hutchinson and General Manager Mel Trebilcock, CNBP’s research focus and innovation strategy was discussed with the visit also including a laboratory tour, allowing MP Gardner to meet with staff and students.
Feedback from the MP was extremely positive citing an ‘inspirational afternoon at CNBP’ with ‘cutting edge science with practical applications.’